Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-106476
Filing Date
2024-12-06
Accepted
2024-12-06 16:05:25
Documents
85
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0223497-10q_synergy.htm   iXBRL 10-Q 842745
2 CERTIFICATION ea022349701ex31-1_synergy.htm EX-31.1 17801
3 CERTIFICATION ea022349701ex31-2_synergy.htm EX-31.2 17787
4 CERTIFICATION ea022349701ex32-1_synergy.htm EX-32.1 3856
5 CERTIFICATION ea022349701ex32-2_synergy.htm EX-32.2 3855
  Complete submission text file 0001213900-24-106476.txt   6858216

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE snyr-20240930.xsd EX-101.SCH 65235
7 XBRL CALCULATION FILE snyr-20240930_cal.xml EX-101.CAL 48543
8 XBRL DEFINITION FILE snyr-20240930_def.xml EX-101.DEF 314198
9 XBRL LABEL FILE snyr-20240930_lab.xml EX-101.LAB 570125
10 XBRL PRESENTATION FILE snyr-20240930_pre.xml EX-101.PRE 329711
88 EXTRACTED XBRL INSTANCE DOCUMENT ea0223497-10q_synergy_htm.xml XML 742727
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42374 | Film No.: 241532283
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)